ask="1.10"
ask_size="600"
average_daily_volume="109029"
bid="1.00"
bid_size="300"
book_value="0.69"
change="+0.00"
change_from_200_day_moving_average="-0.40"
change_from_50_day_moving_average="-0.18"
change_from_52_week_high="-6.91"
change_From_52_week_low="0.12"
change_in_percent="+0.00%"
close="1.04"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.16"
ebitda="-17.60M"
eps_estimate_current_year="-0.82"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="7095000"
high="1.08"
high_52_weeks="7.95"
last_trade_date="2/28/2017"
last_trade_price="1.04"
last_trade_size="600"
last_trade_time="4:00pm"
low="1.01"
low_52_weeks="0.92"
market_capitalization="17.05M"
moving_average_200_day="1.44"
moving_average_50_day="1.22"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.00"
open="1.03"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-27.81%"
percent_change_from_50_day_moving_average="-15.06%"
percent_change_from_52_week_high="-86.92%"
percent_change_from_52_week_low="+13.02%"
previous_close="1.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.50"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.59"
stock_exchange="NGM"
symbol="ORPN"
volume="45942"
weeks_range_52="0.92 - 7.95"
